In line with our data, Hardikar et al. reported a twofold increased risk of developing EACs in 411 patients with Barrett’s esophagus after dichotomization of systemic IL-6 levels based on median splits [18]. The gene discussed is IL6; the disease is esophageal adenocarcinoma.